摘要

We have investigated the effects of agaricoglycerides (AG) in a mouse model of hepatic I/R injury. I/R triggered increases/changes in markers of liver injury, hepatic oxidative stress, tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and nuclear factor kappa B (NF-kappa B). AG significantly reduced the extent of liver inflammation and oxidative stress and also attenuated the NF-kappa B activation as well as TNF-alpha and IL-1 beta production. Our results indicate that AG may represent a novel protective strategy against I/R-induced injury and inflammatory diseases.